Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

172.60
Delayed Data
As of Mar 27
 -0.03 / -0.02%
Today’s Change
86.00
Today|||52-Week Range
172.98
+50.17%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$10.9B

Company Description

Salix Pharmaceuticals Ltd. is a specialty pharmaceutical company, which acquires, develops and commercializes prescription drugs and medical devices used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract. It offers products such as Anusol, Proctocort, Apriso, Azasan, Colazal, Deflux, Diuril, Giazo, Glumetza, Metozolv ODT, MoviPrep, OsmoPrep, Pepcid, Relistor, Ruconest, Solesta, Xifaxan 550 mg and Xifaxan 200 mg, Zegerid. The company was founded by Randy W. Hamilton and Lorin K. Johnson was founded in December 1993 and is headquartered in Raleigh, NC.

Contact Information

Salix Pharmaceuticals Ltd.
8510 Colonnade Center Drive
Raleigh North Carolina 27615
P:(919) 862-1000
Investor Relations:

Employees

Shareholders

Other institutional69.09%
Mutual fund holders44.13%
Individual stakeholders12.59%

Top Executives

Thomas W. D'AlonzoChairman, President & Chief Executive Officer
William C. BertrandCOO, Secretary & General Counsel
Timothy J. CreechCFO, Senior VP-Finance & Administrative Services
William P. ForbesPresident-Medical, Research & Development
Richard D. ScruggsExecutive Vice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account